Grant Name: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Funding Organization: National Cancer Institute (NCI), National Institutes of Health (NIH)
Total Funding Amount: $4,200,000
Duration: Up to 3 years
Primary Objective: Support exploratory research projects focused on innovative technologies for cancer research.
Key Stakeholders: Researchers in cancer biology, clinical diagnosis, treatment, and epidemiology.
Funding Source: Federal government (NIH).
Significance: Part of the broader Innovative Molecular Analysis Technologies (IMAT) Program.
Grant Frequency: One-time funding opportunity.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with or without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City Governments
Indian/Native American Tribal Governments (both Federally Recognized and others)
Federal Government Agencies
Foreign Organizations
No specific qualifications or certifications required.
Organizations must complete necessary registrations (SAM, eRA Commons) prior to application.
Development of innovative technologies for molecular and cellular analysis in cancer research.
Technologies must enhance research in cancer biology, early detection, clinical diagnosis, treatment, and epidemiology.
Technologies should demonstrate potential for substantial improvements over existing methods.
Applications must include quantitative performance measures.
No specific technical expertise required, but projects must demonstrate innovative approaches.
Maximum grant amount: $150,000 per year.
Total project period may not exceed 3 years.
Application Due Date: October 3, 2025.
Open Date: March 4, 2025.
Must comply with NIH Grants Policy Statement and federal regulations.
Follow instructions in the Research (R) Instructions in the How to Apply - Application Guide.